Brief: MedinCell: FDA Approves Expanded Indication For Uzedy

Medincell SA

13/10/2025 08:27

Oct 13 (Reuters) - Medincell SA MEDCL.PA:

ANNOUNCED ON FRIDAY THAT FDA APPROVED EXPANDED INDICATION FOR UZEDY (RISPERIDONE) EXTENDED-RELEASE INJECTABLE SUSPENSION AS A TREATMENT FOR ADULTS LIVING WITH BIPOLAR I DISORDER

JOINT ANNOUNCEMENT WITH TEVA PHARMACEUTICALS TEVA.TA

Source text: ID:nGNX3QPM9L

Further company coverage: MEDCL.PA

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))